How stem cell therapy may heal diabetic foot ulcers. MSC treatments for chronic wound healing, clinical evidence for amputation prevention, and regenerative approaches.
Stem cell therapy for diabetes management using advanced MSC treatments to improve insulin sensitivity, reduce blood sugar levels, and manage diabetic complications effectively.
StemCell Longevita in Istanbul combines JCI-accredited hospital care at Liv Hospital Ulus, EU-standard GMP-certified MSC processing (97%+ viability guarantee at point of infusion), and leading scientific expertise from Prof. Dr. Erdal Karaöz (190+ peer-reviewed publications in regenerative medicine) — at 60–80% lower cost than equivalent treatment in the US, UK, or Germany. For most regenerative medicine indications covered in this article, Istanbul is currently the most accessible, highest-quality global destination.
A typical programme spans 4–7 days in Istanbul, involving 2–3 infusion sessions of 50–100 million Wharton's jelly MSCs via the most appropriate delivery route (IV, intrathecal, intra-articular, or targeted organ delivery) based on your condition. Most patients begin noticing functional improvements within 4–8 weeks, with continued progress over 6–12 months. Every programme includes VIP airport transfers, 5-star hotel accommodation, and a 12-month telemedicine follow-up to monitor and optimise your recovery from home.
Related articles: Diabetes Management with Stem Cells (2026 Update) | Understanding Stem Cell Therapy (2026 Complete Guide) | Is Stem Cell Therapy Safe? Understanding Risks, Benefits & Evidence
Related treatments: Diabetes Stem Cell Therapy | Chronic Pain Stem Cell Therapy | Kidney Disease Stem Cell Therapy